Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin 1-7 in Heart Failure Patients at Risk for VCID and ADRD
NCT05336175Phase 2Unknown
- Sponsor
- University of Arizona
- Start
- Apr 2022
- Primary completion
- Dec 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of angiotensin-(1-7) in vascular cognitive impairment (VCI), Alzheimer's disease (AD), sponsored by University of Arizona. Status: unknown.
02
Drugs
angiotensin-(1-7)
03
Conditions
vascular cognitive impairment (VCI)Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05336175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05336175.